MedTrace Logo

Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO )

NCT06741774 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2024-12-19

No results posted yet for this study

Summary

It is a prospective, multicenter, randomized, open label, parallel controlled, superiority clinical trial that evaluate efficacy and safety of Trabecular Meshwork Microstent Drainage System in Reducing Intraocular Pressure in Adult Patients With Mild to Moderate Open-angle Glaucoma Combined With Cataract.

Conditions

  • Open-angle Glaucoma
  • Cataract

Interventions

DEVICE

Trabecular Meshwork Microstent Drainage System

The device is implanted on the functional trabecular meshwork with head in schlemm canal and tail in anterior chamber. There is a hollow tube connecting schlemm canal and anterior chamber. The device can promote external drainage of aqueous humor to reduce intraocular pressure.

PROCEDURE

phacoemulsification

Eyes with OAG and cataracts randomly divided into control group that were planned for phacoemulsification alone.

Sponsors & Collaborators

  • Healthguard Biomed

    lead INDUSTRY

Principal Investigators

  • Xinghuai Sun, Doctor · EENT hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2025-12-04
Completion
2026-05-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06741774 on ClinicalTrials.gov